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Prevalence 
 
•It is the commonest chronic 
disease. 
•It occurs in adults and 
children at rates approaching 
1% of the population. 
•It affects developed and 
underdeveloped countries. 
• Its epidemiology is like an 
iceberg most affected 
people with coeliac disease 
remains undiagnosed. 
 
Coeliac disease is a intolerance to the gluten found in wheat, 
barley and rye.  The intestinal mucosa becomes damaged by an 
autoimmune response that is initiated by  peptide fragment from 
the gluten component α-gliadin, leading to severe  
malabsorption. 
Developing the disease is related to the presence of alleles that 
encode for HLA-DQ2 or HLA-DQ8 proteins. 
 
Villous atrophy 
 
 
 
There is a complete loss of villi 
and hypertrophy of the mucosa 
that results in a flat mucosa. 
Coeliac disease is an autoimmune process triggered by an external factor such as gluten in genetically predisposed people .  
The only way to prevent it is to eliminate gluten from the diet. 
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Immunological process 
The immune response includes an innate component responsible for epithelial injury, and other adaptive components mediated by CD4 
+ T cells specific of the lamina propria that cause a mucosa remodeling.  
 
Gluten  is digested by enzymes into 
peptides. In the epithelium, gliadin 
damages epithelial cells, resulting in 
increased expression of interleukin-15, 
which in turn activates intraepithelial 
lymphocytes. These lymphocytes 
become cytotoxic and kill enterocytes. 
During infections or as result of 
permeability changes, gliadin enters the 
lamina propria, where it is deamidated 
by tissue transglutaminase, allowing 
presentation by HLA-DQ on the surface 
of antigen-presenting cells. Gliadin is 
presented to gliadin-reactive CD4+ T 
cells through a T-cell receptor, resulting 
in the production of cytokines that 
cause tissue damage. 
 
 
Genetic factor 
 
When the gliadin is deamidated by 
transglutaminase enzym, it exposes 
negatively charged amino acids and 
this epitope has a high affinity for the 
HLA-DQ molecule. 
There is a strong genetic component to 
CD: almost all patients  carry the HLA-
DQ2 allele and rarely DQ8. 
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